ФГБУ
National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
Bone marrow transplantation in the branches of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation.

Bone marrow transplantation in the branches of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation.

In National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation is used to treat tumors of the hematopoietic and lymphoid tissues.

Branches of NMRRC where bone marrow transplantation is performed

Department of High-Dose Chemotherapy with Bone Marrow Transplantation Unit of P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

МНИОИ им. П.А. Герцена

Department of Radiotherapy and Chemotherapy for Hemoblastosis of A. Tsyb Medical Radiological Research Centre - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

МРНЦ им. А.Ф. Цыба

Specialists

Falaleeva Natalia Aleksandrovna

Head of the Chemotherapy Department of A. Tsyb Medical Radiological Research Centre - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation Doctor of Medical Sciences Leading specialist in the field of chemotherapy for cancer. Author of unique patented methods of anticancer therapy.
The team of specialists of A. Tsyb MRRC:
Nekrasova A.A.
Nemykin V.N.
Terekhova A.Yu.
Grivtsova L.Yu.
Shkliaev S.S.
Terentieva A.V.

Chervontseva Alevtina Mikhailovna

Leading researcher, Department of High-Dose Chemotherapy with Bone Marrow Transplantation Unit of P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation Hematologist PhD Author of unique methods of therapy for tumors of the hematopoietic tissues
The team of specialists of Р. Hertsen MORI:
Gushchina E.E.
Cherkashina I.V.
Lunin V.V.
Khairullina L.S.
Verniuk M.A.

The main goal of bone marrow transplantation

  • Treatment of stage IV cancer of the hematopoietic and lymphoid systems

  • Improvement of blood cell formation

  • Restoration of hematopoietic function

Bone marrow transplantation is performed for the following diseases

The main indications for high-dose chemotherapy, followed by autologous hematopoietic stem cell transplantation (auto-HSCT) are:
- Hodgkin's lymphoma and non-Hodgkin's lymphoma in cases of ineffectiveness of standard therapy or in case of recurrence of these diseases;
- Multiple myeloma when the majority of primary patients (up to 65 years old) require consolidation after the first line chemotherapy.
In A. Tsyb MRRC high-dose chemotherapy followed by auto-HSCT is carried out for HIV-infected patients with Hodgkin's lymphoma and non-Hodgkin's lymphomas.

Preparing for treatment

In order to identify possible contraindications and timely prevention of complications, patients are recommended to perform the following examinations within a month before autologous hematopoietic stem cell transplantation (auto-HSCT):
- complete blood count (including white blood cell differential) and biochemical blood test (uric acid, electrolytes, creatinine, calcium, phosphates, urea, liver tests, C-reactive protein, lactate dehydrogenase and glucose);

Show

Stages of this type of treatment

Modern chemotherapy strategies allow us to achieve long-term complete remission (recovery) in a significant number of patients with various types of lymphomas. However, in some patients, the use of standard doses of chemotherapy drugs does not allow achieving complete destruction of the tumor or the antitumor effect is short-term, i.e. some time after the end of treatment, a relapse of the disease may develop. In such cases, second line induction chemotherapy (3-4 courses) is carried out and then, at the peak of the effect of this treatment, it becomes necessary to carry out high-dose consolidation, followed by autologous hematopoietic stem cell transplantation (auto-HSCT).

Show

Recommendations for patients of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation and its branches

Patient route

Before taking a decision on this type of treatment the patient and their relatives can have a conversation with a specialist who will explain how the treatment is performed. Then, the patient or their legal representative signs a consent to high-dose chemotherapy, followed by autologous hematopoietic stem cell transplantation (auto-HSCT).
For better organization and continuity in patient treatment, it is recommended to contact us by phone +7 (495) 945 83 85 and then send us all medical documents so that the council of doctors will decide if this method of treatment is appropriate for a particular patient. Then, the doctors will determine in which branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation it is better for the patient to undergo this method of treatment. In case of a positive answer, the patient will be informed of the specific date of admission to the Center.

The cost of treatment depends on the high-dose consolidation regimen, the need for an additional course of chemotherapy in order to stimulate the release of hematopoietic cells, the length of hospital stay and the amount of accompanying treatment in the post-transplant period; the cost can range from 1 to 2 million rubles. More specific information can be provided after reviewing the patient's medical records.
Contact us:
tel. +7 (495) 945 83-85

The Coast of Treatment in P.Hertsen Moscow Oncology Research Institute (MORI), branch of NMRRC of the Ministry of Health of Russian Federation

+7 (495) 945-83-85
    Information

Working hours:
с 8:00 до 20:00 (working days)